Ben Towne Center


Every purchase supports groundbreaking pediatric cancer research.

In 2010, Ben Towne Foundation was started in Seattle Washington by Jeff and Carin Towne, with the mission to accelerate the pace of pediatric cancer research and change the way childhood cancers are treated and cured. In five short years, the Foundation has done just that. Partnering with Seattle Children's they established the Ben Towne Center for Childhood Cancer Research, three FDA clinical trials are open, and most importantly dozens of children are in remission! Callie's is proud to support this important work. Every time you purchase Callie's coffee and gifts, we give 10% of sales to the Ben Towne Center.

The Ben Town Foundation
childhood cancer facts
  1. Cancer is the leading cause of death by disease among U.S. children between infancy and age 15. (NCI)
  2. About 11,630 children in the United States under the age of 15 will be diagnosed with cancer in 2013. (ACS)
  3. Every day, 36 children are diagnosed with cancer. (COG)
  4. About 1,310 children are expected to die from cancer in 2013. (ACS)
  5. More than 40,000 children undergo treatment for cancer each year. (COG)
  6. Pediatric cancers receive less than 3% of the National Cancer Institute budget. (MCT)

The Research

Dr. Michael Jensen: A world without cancer

The focus of the Ben Towne Center for Childhood Cancer Research is to develop innovative new therapies in its laboratories then apply these advances, on an accelerated timetable, to groundbreaking clinical trials for children with the most aggressive forms of cancer. The ultimate goal of the Center is to eventually replace cancer therapies such as radiation and chemotherapy with new, “smart” therapies capable of harnessing the power of the body’s immune system to eliminate cancer with precision, while leaving the body unharmed. The aim is to advance the care of children with cancer to the point when all children can be cured in a manner that does not diminish their future health and emotional well-being.
fighting pediatric cancer

Watch ‘The Mighty T,’ an animated short film about this cutting edge research.

On July 11, Dr. Jensen and his team announced that the first patient to go through Phase 1 clinical trials had a positive response to T-cell therapy, with results showing no evidence of cancer after only seven days. It is a moment to celebrate on behalf of the young patient, and a milestone in the fight toward a cure for pediatric cancers!

KOMO | Seattle Children’s Announcements